European Journal of Chemistry

Synthesis, crystal structure, Hirshfeld surface and interaction energies analysis of 3-(benzo[d][1,3]dioxol-5-yl)-2-(pyridin-3-yl)thiazolidin-4-one

Crossmark


Main Article Content

Summara Kousar
Raed Al-Qawasmeh
Monther Khanfar
Muhammad Saeed

Abstract

3-(Benzo[d][1,3]dioxol-5-yl)-2-(pyridin-3-yl)thiazolidin-4-one, a novel derivative of 1,3-thiazolidin-4-one, was synthesized by Schiff base formation followed by cyclocondensation with thioglycolic acid. The structure of the synthesized compound was characterized by spectroscopic techniques, including NMR, GC-MS, and HRMS. The molecular structure was unambiguously established by single-crystal X-ray diffraction. The compound crystallizes in the monoclinic crystal system with space group C2/c (No. 15) and unit-cell parameters a = 14.69 Å, b = 9.615 Å, c = 22.198 Å, and β = 98.49°. The molecular geometry reveals that the sulfur atom of the 1,3-thiazolidin-4-one ring is significantly out of the plane of the remaining ring atoms and adopts a puckered conformation. In the solid state, the supramolecular architecture is stabilized by a combination of interactions, including hydrogen bonding and weak π···π interactions. Furthermore, Hirshfeld surface analysis and two-dimensional fingerprint plots were used to quantify the intermolecular interactions, revealing that H···H (32.4%), O···H/H···O (20.2%) C···H/H···C (18.1%) contacts make the most significant contribution to Hirshfeld surfaces. Energy framework calculations indicated that dispersion energy, arising mainly from π···π interactions, is the dominant contributor to stabilization of the crystal packing.


icon graph This Abstract was viewed 7 times | icon graph Article PDF downloaded 1 times icon graph Article CIF FILE downloaded 0 times

How to Cite
(1)
Kousar, S.; Al-Qawasmeh, R.; Khanfar, M.; Saeed, M. Synthesis, Crystal Structure, Hirshfeld Surface and Interaction Energies Analysis of 3-(benzo[d][1,3]dioxol-5-Yl)-2-(pyridin-3-yl)thiazolidin-4-One. Eur. J. Chem. 2026, 17, 99-108.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Kabir, E.; Uzzaman, M. A review on biological and medicinal impact of heterocyclic compounds. Results Chem. 2022, 4, 100606.
https://doi.org/10.1016/j.rechem.2022.100606

[2]. Brown, F. C. 4-Thiazolidinones. Chem. Rev. 1961, 61 (5), 463-521.
https://doi.org/10.1021/cr60213a002

[3]. Jain, A. K.; Vaidya, A.; Ravichandran, V.; Kashaw, S. K.; Agrawal, R. K. Recent developments and biological activities of thiazolidinone derivatives: A review. Bioorg. Med. Chem. 2012, 20 (11), 3378-3395.
https://doi.org/10.1016/j.bmc.2012.03.069

[4]. Patel, D.; Kumari, P.; Patel, N. Synthesis and biological evaluation of some thiazolidinones as antimicrobial agents. Eur. J. Med. Chem. 2012, 48, 354-362.
https://doi.org/10.1016/j.ejmech.2011.11.041

[5]. Goel, B.; Ram, T.; Tyagi, R.; Bansal, E.; Kumar, A.; Mukherjee, D.; Sinha, J. N. 2-Substituted-3-(4-bromo-2-carboxyphenyl)-5-methyl-4-thiazolidinones as potential anti-inflammatory agents. Eur. J. Med. Chem. 1999, 34, 265-269.
https://doi.org/10.1016/S0223-5234(99)80060-9

[6]. Hu, J.; Wang, Y.; Wei, X.; Wu, X.; Chen, G.; Cao, G.; Shen, X.; Zhang, X.; Tang, Q.; Liang, G.; Li, X. Synthesis and biological evaluation of novel thiazolidinone derivatives as potential anti-inflammatory agents. Eur. J. Med. Chem. 2013, 64, 292-301.
https://doi.org/10.1016/j.ejmech.2013.04.010

[7]. Moreira, D. R.; Lima Leite, A. C.; Cardoso, M. V.; Srivastava, R. M.; Hernandes, M. Z.; Rabello, M. M.; da Cruz, L. F.; Ferreira, R. S.; de Simone, C. A.; Meira, C. S.; Guimaraes, E. T.; da Silva, A. C.; dos Santos, T. A.; Pereira, V. R.; Pereira Soares, M. B. Structural Design, Synthesis and Structure-Activity Relationships of Thiazolidinones with Enhanced Anti‐Trypanosoma cruzi Activity. ChemMedChem 2013, 9 (1), 177-188.
https://doi.org/10.1002/cmdc.201300354

[8]. de Oliveira Filho, G. B.; de Oliveira Cardoso, M. V.; Espíndola, J. W.; Ferreira, L. F.; de Simone, C. A.; Ferreira, R. S.; Coelho, P. L.; Meira, C. S.; Magalhaes Moreira, D. R.; Soares, M. B.; Lima Leite, A. C. Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi. Bioorg. Med. Chem. 2015, 23 (23), 7478-7486.
https://doi.org/10.1016/j.bmc.2015.10.048

[9]. Gamal, M. A.; Fahim, S. H.; Giovannuzzi, S.; Fouad, M. A.; Bonardi, A.; Gratteri, P.; Supuran, C. T.; Hassan, G. S. Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II. Eur. J. Med. Chem. 2024, 271, 116434.
https://doi.org/10.1016/j.ejmech.2024.116434

[10]. Saeedian Moghadam, E.; Sameem, B.; Abdel-Jalil, R.; Faramarzi, M. A.; Amini, M. 5-Benzylidene-2,3-diarylthiazolidine-4-ones: Design, synthesis, spectroscopic characterization, in vitro biological and computational evaluation. Synth. Commun. 2021, 51 (17), 2668-2683.
https://doi.org/10.1080/00397911.2021.1946699

[11]. Barbosa, V. A.; Baréa, P.; Mazia, R. S.; Ueda-Nakamura, T.; Costa, W. F.; Foglio, M. A.; Goes Ruiz, A. L.; Carvalho, J. E.; Vendramini-Costa, D. B.; Nakamura, C. V.; Sarragiotto, M. H. Synthesis and evaluation of novel hybrids β -carboline-4-thiazolidinones as potential antitumor and antiviral agents. Eur. J. Med. Chem. 2016, 124, 1093-1104.
https://doi.org/10.1016/j.ejmech.2016.10.018

[12]. Chen, H.; Yang, T.; Wei, S.; Zhang, H.; Li, R.; Qin, Z.; Li, X. Synthetic bicyclic iminosugar derivatives fused thiazolidin-4-one as new potential HIV-RT inhibitors. Bioorg. Med. Chem. Lett. 2012, 22 (23), 7041-7044.
https://doi.org/10.1016/j.bmcl.2012.09.100

[13]. Cheddie, A.; Shintre, S. A.; Bantho, A.; Mocktar, C.; Koorbanally, N. A. Synthesis and antibacterial activity of a series of 2‐trifluoromethylbenzimidazole‐thiazolidinone derivatives. J. Heterocycl. Chem. 2019, 57 (1), 299-307.
https://doi.org/10.1002/jhet.3777

[14]. Cascioferro, S.; Parrino, B.; Carbone, D.; Schillaci, D.; Giovannetti, E.; Cirrincione, G.; Diana, P. Thiazoles, Their Benzofused Systems, and Thiazolidinone Derivatives: Versatile and Promising Tools to Combat Antibiotic Resistance. J. Med. Chem. 2020, 63 (15), 7923-7956.
https://doi.org/10.1021/acs.jmedchem.9b01245

[15]. Singh, N.; Agarwal, R. C.; Singh, C. P. Synthesis and Evaluation of Some Substituted Indole Derivatives for Cardiovascular Activity. Int. J. Pharm. Sci. Drug Res. 2018, 14-17.
https://doi.org/10.25004/IJPSDR.2013.050102

[16]. Ottanà, R.; Carotti, S.; Maccari, R.; Landini, I.; Chiricosta, G.; Caciagli, B.; Vigorita, M. G.; Mini, E. In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. Bioorg. Med. Chem. Lett. 2005, 15 (17), 3930-3933.
https://doi.org/10.1016/j.bmcl.2005.05.093

[17]. Havrylyuk, D.; Zimenkovsky, B.; Vasylenko, O.; Gzella, A.; Lesyk, R. Synthesis of New 4-Thiazolidinone-, Pyrazoline-, and Isatin-Based Conjugates with Promising Antitumor Activity. J. Med. Chem. 2012, 55 (20), 8630-8641.
https://doi.org/10.1021/jm300789g

[18]. Nirwan, S.; Chahal, V.; Kakkar, R. Thiazolidinones: Synthesis, Reactivity, and Their Biological Applications. J. Heterocycl. Chem. 2019, 56 (4), 1239-1253.
https://doi.org/10.1002/jhet.3514

[19]. Bolla, G.; Sarma, B.; Nangia, A. K. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs. Chem. Rev. 2022, 122 (13), 11514-11603.
https://doi.org/10.1021/acs.chemrev.1c00987

[20]. Desiraju, G. R. Crystal Engineering: From Molecule to Crystal. J. Am. Chem. Soc. 2013, 135 (27), 9952-9967.
https://doi.org/10.1021/ja403264c

[21]. Hamdani, S. S.; Khan, B. A.; Hameed, S.; Batool, F.; Saleem, H. N.; Mughal, E. U.; Saeed, M. Synthesis and evaluation of novel S-benzyl- and S-alkylphthalimide- oxadiazole -benzenesulfonamide hybrids as inhibitors of dengue virus protease. Bioorg. Chem. 2020, 96, 103567.
https://doi.org/10.1016/j.bioorg.2020.103567

[22]. Batool, F.; Saeed, M.; Saleem, H. N.; Kirschner, L.; Bodem, J. Facile Synthesis and In Vitro Activity of N-Substituted 1,2-Benzisothiazol-3(2H)-ones against Dengue Virus NS2BNS3 Protease. Pathogens 2021, 10 (4), 464.
https://doi.org/10.3390/pathogens10040464

[23]. Bruker (2008). SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.

[24]. Krause, L.; Herbst-Irmer, R.; Sheldrick, G. M.; Stalke, D. Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination. J. Appl. Crystallogr. 2015, 48 (1), 3-10.
https://doi.org/10.1107/S1600576714022985

[25]. Sheldrick, G. M. SHELXT- Integrated space-group and crystal-structure determination. Acta. Crystallogr. A. Found. Adv. 2015, 71 (1), 3-8.
https://doi.org/10.1107/S2053273314026370

[26]. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta. Crystallogr. C. Struct. Chem. 2015, 71 (1), 3-8.
https://doi.org/10.1107/S2053229614024218

[27]. Farrugia, L. J. ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI). J. Appl. Crystallogr. 1997, 30 (5), 565-565.
https://doi.org/10.1107/S0021889897003117

[28]. Macrae, C. F.; Edgington, P. R.; McCabe, P.; Pidcock, E.; Shields, G. P.; Taylor, R.; Towler, M.; van de Streek, J. Mercury: visualization and analysis of crystal structures. J. Appl. Crystallogr. 2006, 39 (3), 453-457.
https://doi.org/10.1107/S002188980600731X

[29]. Macrae, C. F.; Sovago, I.; Cottrell, S. J.; Galek, P. T. A.; McCabe, P.; Pidcock, E.; Platings, M.; Shields, G. P.; Stevens, J. S.; Towler, M.; Wood, P. A. Mercury 4.0: from visualization to analysis, design and prediction. J. Appl. Crystallogr. 2020, 53, 226-235.
https://doi.org/10.1107/S1600576719014092

[30]. Spek, A. L. Structure validation in chemical crystallography. Acta. Crystallogr. D. Biol. Crystallogr. 2009, 65 (2), 148-155.
https://doi.org/10.1107/S090744490804362X

[31]. Groom, C. R.; Bruno, I. J.; Lightfoot, M. P.; Ward, S. C. The Cambridge Structural Database. Acta. Crystallogr. B. Struct. Sci. Cryst. Eng. Mater. 2016, 72 (2), 171-179.
https://doi.org/10.1107/S2052520616003954

[32]. Barreca, M. L.; Chimirri, A.; De Luca, L.; Monforte, A. M.; Monforte, P.; Rao, A.; Zappalà, M.; Balzarini, J.; De Clercq, E.; Pannecouque, C.; Witvrouw, M. Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg. Med. Chem. Lett. 2001, 11, 1793-1796.
https://doi.org/10.1016/S0960-894X(01)00304-3

[33]. Foroughifar, N.; Ebrahimi, S. One-pot synthesis of 1,3-thiazolidin-4-one using Bi(SCH2COOH)3 as catalyst. Chinese. Chemical. Letters. 2013, 24 (5), 389-391.
https://doi.org/10.1016/j.cclet.2013.03.019

[34]. Elkanzi, N. A.; Bakr, R. B. Optimization of 1,3-thiazolidin-4-one based compounds: Design, synthesis, biological evaluation, molecular modeling and ADME studies. J. Indian Chem. Soc. 2025, 102 (5), 101693.
https://doi.org/10.1016/j.jics.2025.101693

[35]. Barreca, M. L.; Balzarini, J.; Chimirri, A.; Clercq, E. D.; Luca, L. D.; Höltje, H. D.; Höltje, M.; Monforte, A. M.; Monforte, P.; Pannecouque, C.; Rao, A.; Zappalà, M. Design, Synthesis, Structure−Activity Relationships, and Molecular Modeling Studies of 2,3-Diaryl-1,3-thiazolidin-4-ones as Potent Anti-HIV Agents. J. Med. Chem. 2002, 45 (24), 5410-5413.
https://doi.org/10.1021/jm020977+

[36]. War, J. A.; Srivastava, S. K. Rationale design and synthesis of some novel imidazole linked thiazolidinone hybrid molecules as DNA minor groove binders. Eur. J. Chem. 2020, 11 (2), 120-132.
https://doi.org/10.5155/eurjchem.11.2.120-132.1974

[37]. Fun, H.; Hemamalini, M.; Shanmugavelan, P.; Ponnuswamy, A.; Jagatheesan, R. 3-Benzyl-2-phenyl-1,3-thiazolidin-4-one. Acta. Crystallogr. E. Struct. Rep. Online. 2011, 67 (10), o2706-o2706.
https://doi.org/10.1107/S1600536811037706

[38]. Gzella, A. K.; Kowiel, M.; Suseł, A.; Wojtyra, M. N.; Lesyk, R. Heterocyclic tautomerism: reassignment of two crystal structures of 2-amino-1,3-thiazolidin-4-one derivatives. Acta. Crystallogr. C. Struct. Chem. 2014, 70 (8), 812-816.
https://doi.org/10.1107/S2053229614015162

[39]. Abdel-Rahman, L. H.; Mohamed, S. K.; El Bakri, Y.; Ahmad, S.; Lai, C.; Amer, A. A.; Mague, J. T.; Abdalla, E. M. Synthesis, crystal structural determination and in silco biological studies of 3,3′-ethane-1,2-diylbis(2-benzylidene-1,3-thiazolidin-4-one. Journal. of. Molecular. Structure. 2021, 1245, 130997.
https://doi.org/10.1016/j.molstruc.2021.130997

[40]. Rahmani, R.; Djafri, A.; Daran, J.; Djafri, A.; Chouaih, A.; Hamzaoui, F. Crystal structure of (2Z,5Z)-3-(4-methoxyphenyl)-2-[(4-methoxyphenyl)imino]-5-[(E)-3-(2-nitrophenyl)allylidene]-1,3-thiazolidin-4-one. Acta. Crystallogr. E. Cryst. Commun. 2016, 72 (2), 155-157.
https://doi.org/10.1107/S2056989016000207

[41]. Spackman, M. A.; Jayatilaka, D. Hirshfeld surface analysis. CrystEngComm. 2009, 11 (1), 19-32.
https://doi.org/10.1039/B818330A

[42]. Seth, S. K. Structural characterization and Hirshfeld surface analysis of a CoII complex with imidazo[1,2-a]pyridine. Acta. Crystallogr. E. Cryst. Commun. 2018, 74 (5), 600-606.
https://doi.org/10.1107/S2056989018003857

[43]. Spackman, P. R.; Turner, M. J.; McKinnon, J. J.; Wolff, S. K.; Grimwood, D. J.; Jayatilaka, D.; Spackman, M. A. CrystalExplorer: a program for Hirshfeld surface analysis, visualization and quantitative analysis of molecular crystals. J. Appl. Crystallogr. 2021, 54 (3), 1006-1011.
https://doi.org/10.1107/S1600576721002910

[44]. Vu Quoc, T.; Nguyen Ngoc, L.; Do Ba, D.; Pham Chien, T.; Nguyen Huy, H.; Van Meervelt, L. Crystal structure and Hirshfield surface analysis of 4-phenyl-3-(thiophen-3-ylmethyl)-1H-1,2,4-triazole-5(4H)-thione. Acta. Crystallogr. E. Cryst. Commun. 2018, 74 (6), 812-815.
https://doi.org/10.1107/S2056989018007193

[45]. Etse, K. S.; Lamela, L. C.; Zaragoza, G.; Pirotte, B. Synthesis, crystal structure, Hirshfeld surface and interaction energies analysis of 5-methyl-1,3-bis(3-nitrobenzyl)pyrimidine-2,4(1H,3H)-dione. Eur. J. Chem. 2020, 11, 91-99.
https://doi.org/10.5155/eurjchem.11.2.91-99.1973

[46]. McKinnon, J. J.; Jayatilaka, D.; Spackman, M. A. Towards quantitative analysis of intermolecular interactions with Hirshfeld surfaces. Chem. Commun. 2007, 3814-3816.
https://doi.org/10.1039/b704980c

[47]. Gumus, I.; Solmaz, U.; Gonca, S.; Arslan, H. Molecular self-assembly in indole-based benzamide derivative: Crystal structure, Hirshfeld surfaces and antimicrobial activity. Eur. J. Chem. 2017, 8 (4), 349-357.
https://doi.org/10.5155/eurjchem.8.4.349-357.1637

[48]. Chandramohan, U. M.; Joseph, D. Hirshfeld surface, fukui function, molecular docking, molecular dynamics investigation on human immunodeficiency virus-1 (HIV) organism with 2,6-dibromo-4-chloroaniline. Results Chem. 2024, 11, 101815.
https://doi.org/10.1016/j.rechem.2024.101815

[49]. Tan, S. L.; Jotani, M. M.; Tiekink, E. R. Utilizing Hirshfeld surface calculations, non-covalent interaction (NCI) plots and the calculation of interaction energies in the analysis of molecular packing. Acta. Crystallogr. E. Cryst. Commun. 2019, 75 (3), 308-318.
https://doi.org/10.1107/S2056989019001129

[50]. Jayatilaka, D.; Grimwood, D. J. Tonto: A FORTRAN based object-oriented system for quantum chemistry and crystallography. In Lecture Notes in Computer Science; Springer Berlin Heidelberg: Berlin, Heidelberg, 2003; pp. 142-151.
https://doi.org/10.1007/3-540-44864-0_15

[51]. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian 16. Gaussian, Inc., Wallingford CT, 2016.

[52]. Sieffert, N.; Wipff, G. Uranyl extraction by N,N-dialkylamide ligands studied using static and dynamic DFT simulations. Dalton Trans. 2015, 44, 2623-2638.
https://doi.org/10.1039/C4DT02443E

[53]. Turner, M. J.; Thomas, S. P.; Shi, M. W.; Jayatilaka, D.; Spackman, M. A. Energy frameworks: insights into interaction anisotropy and the mechanical properties of molecular crystals. Chem. Commun. 2015, 51 (18), 3735-3738.
https://doi.org/10.1039/C4CC09074H

[54]. Mackenzie, C. F.; Spackman, P. R.; Jayatilaka, D.; Spackman, M. A. CrystalExplorermodel energies and energy frameworks: extension to metal coordination compounds, organic salts, solvates and open-shell systems. IUCrJ. 2017, 4 (5), 575-587.
https://doi.org/10.1107/S205225251700848X

Supporting Agencies

Lahore University of Management Sciences, under Faculty Initiative Funds (FIF-0918/CH), Lahore, Pakistan.
Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

License Terms

by-nc

Copyright © 2026 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).